Thanks again Mozz for the phenomenal amount of work you put into this community. Since becoming interested in Paradigm as an investment ~18months ago, just keeping up with your whitepapers and doing my best to ensure I've fully understood/validated where possible often feels like part-time job ... I can only imagine how much time you've put into preparing your reports.
If I didn't get the sense that you've shown your face at a couple of previous meet-ups, I'd be convinced that you were on the company payroll (and wouldn't even be upset).
Assuming that you aren't already on the payroll, and that you're not claiming brokerage report/coverage style fees ... I'd be supportive of Paradigm of Paradigm branding their next product Mozzarc® as a trophy. ... It actually rolls off the tongue better than Zilusol, but still sounds druggy-enough.
PAR Price at posting:
$2.53 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)